XML 68 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Other Comprehensive Loss (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Consolidated Statements of Other Comprehensive Loss [Abstract]    
Net loss $ (99,040) $ (37,324)
Unrealized gains/(losses) on available-for-sale securities 1,329 94
Comprehensive net loss attributable to Amylin Pharmaceuticals, Inc. shareholders $ (97,711) $ (37,230)